Cargando…
Impact of COVID-19 on Healthcare Resource Utilisation Among Patients with Inflammatory Bowel Disease in the USA
BACKGROUND AND AIMS: The impact of the COVID-19 pandemic on patients with inflammatory bowel disease [IBD] is largely unknown. We characterised the impact of COVID-19 on IBD care by conducting an analysis of US health care claims data. METHODS: We obtained de-identified, open-source, health insuranc...
Autores principales: | Ungaro, Ryan C, Chou, Bonnie, Mo, Jason, Ursos, Lyann, Twardowski, Rachel, Candela, Ninfa, Colombel, Jean-Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047243/ https://www.ncbi.nlm.nih.gov/pubmed/35396598 http://dx.doi.org/10.1093/ecco-jcc/jjac056 |
Ejemplares similares
-
Real-World Effectiveness of Vedolizumab Dose Escalation in Patients With Inflammatory Bowel Disease: A Systematic Literature Review
por: Patel, Dipen, et al.
Publicado: (2022) -
COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021) -
Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient
por: Dunleavy, Katie A, et al.
Publicado: (2021) -
Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
por: Hibi, Toshifumi, et al.
Publicado: (2021) -
Vitamin D status in pediatric irritable bowel syndrome
por: Nwosu, Benjamin Udoka, et al.
Publicado: (2017)